| HOME >> BIOLOGY >> TECHNOLOGY |
Rising Prominence of Indian Biosimilar Industry Worldwide 75
Overcoming Current Limitations Remains the Key 75
Biosimilars Interlace Opportunities and Snags for Indian
Companies 75
Indian Pharmaceutical Companies Ogle Cancer Market 76
Indian Pharma Majors Gear Up For Biosimilars Fray 76
Select Major Indian Companies' Marketed and Pipeline
Biosimilars 76
Indian Firms Eyeing European Market 77
Select Leading Indian Companies Planning to Enter
European Market 78
Indian Biogeneric Drugs to Enter the US Market 78
B.Market Analytics 79
Table 22: Rest of World Recent Past, Current & Future
Analysis for Biosimilars - Annual Sales Figures in US$
Million for Years 2008 through 2015 (includes corresponding
Graph/Chart) 79
COMPETITIVE LANDSCAPE
Total Companies Profiled: 55 (including Divisions/Subsidiaries - 61)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 11
Canada 2
Europe 16
France 1
Germany 10
The United Kingdom 2
Rest of Europe 3
Asia-Pacific (Excluding Japan) 28
Latin America 1
Africa 1
Middle East 2
------------------------------------------
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
<| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |